Chandrima Majumdar

@c-majumdar.bsky.social

Ribosomes have a strange protein modification in a universally-conserved protein uS11. This modification, isoaspartate, is also conserved in nearly all forms of life. We originally found this modification using cryo-EM, but had no idea how it was formed. 1/ elifesciences.org/articles/60482

Structure of the bacterial ribosome at 2 Å resolution

High-resolution maps and models of the bacterial ribosome provide new chemical insights into protein synthesis, and should enable the development of robust tools for cryo-EM structure modeling and ref...

elifesciences.org

Chintan's work demonstrating the efficient incorporation of non-α-amino acid backbones into proteins expressed in both E. coli and mammalian cells just came out! A great collaborative effort from @cgemcci.bsky.social! pubs.acs.org/doi/10.1021/...

Co-Translational Incorporation of (R)- and (S)-β2-Hydroxyacids In Vivo: Directed Evolution of Efficient Aminoacyl-tRNA Synthetases

Expanding the genetic code of living cells with noncanonical monomers (ncMs) relies on engineered aminoacyl-tRNA synthetases (aaRS) and their cognate tRNAs. Conventional aaRS engineering strategies rely on translation-dependent selection systems, limiting their utility for ncMs that are poorly accommodated by the native translational machinery. To address this limitation, we recently developed START, a translation-independent platform that selects Methanomethylophilus alvus pyrrolysyl-synthetase (MaPylRS) mutants based on their ability to acylate cognate tRNAMaPyl. START uses barcoded tRNAs to encode the identity of distinct aaRS mutants in a library. Acylation by active aaRS mutants protects the corresponding tRNAs from periodate oxidation, and their identity is retrieved subsequently through sequencing. START was previously applied to genetically encode noncanonical α-amino acids. Here, we successfully applied START to engineer MaPylRS mutants capable of acylating tRNAMaPyl with diverse non-α-amino acid substrates with good efficiency and fidelity, including (R) and (S) enantiomers of a β2-hydroxy acid, a β2-amino acids, and a malonate. Several mutants exhibit notable polyspecificity across noncanonical backbones while maintaining selectivity against their α-amino acid counterparts. Using these novel enzymes, we demonstrate the ribosomal incorporation of both (R)- and (S)-β2-hydroxy acids into a luciferase reporter protein expressed in Escherichia coli with good efficiency and fidelity. These results imply that highly active engineered aaRS/tRNA pairs can overcome the recently established limitations of EF-Tu with respect to non-α-amino acid substrates. The engineered MaPylRS mutants also enabled the successful incorporation of both (R)- and (S)-β2-hydroxy acids into a protein expressed in mammalian cells, demonstrating for the first time that eukaryotic translation can accommodate non-α-backbones.

pubs.acs.org

In the latest installment of @asbmb.bsky.social 's career exploration podcast, "In conversation with..." Lou Stancato, VP of Enabling Technologies at the Indiana Biosciences Research Institute shares insights from his career: www.asbmb.org/career-resou...

In conversation with...

Engaging discussions with biological and life sciences professionals about their career journeys and the various opportunities available to graduate students and postdocs.

asbmb.org

Check out the latest episodes of the #ASBMB podcast Cindy Khuu shares her story of pursuing a career in regulatory affairs Nisha Cavanaugh, talks about her role in research administration Shyretha Brown, shares her experience as the director of a non-profit! www.asbmb.org/career-resou...

In conversation with...

Engaging discussions with biological and life sciences professionals about their career journeys and the various opportunities available to graduate students and postdocs.

asbmb.org

Preprint alert! ✨ In this project that I co-led with @benadler.bsky.social, we show that a miniature CRISPR-Cas10-like enzyme, mCpol, uses a novel inverse signaling mechanism to prevent the spread of viruses that attempt immune evasion by depleting host cyclic nucleotides. Check it out:

A miniature CRISPR-Cas10 enzyme confers immunity by an inverse signaling pathway

Microbial and viral co-evolution has created immunity mechanisms involving oligonucleotide signaling that share mechanistic features with human anti-viral systems. In these pathways, including CBASS a...

biorxiv.org

This was such a fun and insightful workshop! I love 10k Sciences mission to make science more accessible and easily understandable using the latest technology!

10k Science@10k.science · last yr.

We just completed our third 10k Science Communication Bootcamp! 🧬 Four UC Berkeley scientists visualized their research like never before: 10k.science/bootcamp-3 Special thanks to our bootcamp experts: @jiwasa.bsky.social, Dee Rossiter, and @meganhoch.bsky.social! #SciComm #SciViz #PhDSky #science

I had the pleasure of co-hosting this new career exploration podcast from ASBMB- tune in to hear from my fellow committee member Tom Kiselak about being a patent attorney!

American Society for Biochemistry and Molecular Biology@asbmb.bsky.social · 2y ago

🎙️ASBMB's new series features interviews with biological and life sciences professionals about their careers! ow.ly/268250UYcmx 🎧Check out episode 1: A conversation w/Tom Kiselak (Thermo Fisher Scientific), who holds a #PhD in analytical chemistry & works as a patent attorney: youtu.be/enBtSSTQT9A.